top of page

Glaucoma: The Silent Thief of Sight—and What You Can Do About It

Have you ever wondered how a condition can slowly steal vision without causing pain, redness, or obvious warning signs? This is exactly why glaucoma remains one of the most misunderstood and underestimated eye diseases today. Many patients are shocked when they hear the diagnosis, not because they ignored symptoms, but because there were none to notice. Understanding glaucoma is the first and most powerful step toward protecting your sight.



 South Bay Retina |  Understanding Glaucoma: Often called the "silent thief of sight," glaucoma can develop without symptoms, posing a risk to those with high blood pressure, age over 40, specific ethnic backgrounds, and myopia. Highlighting the importance of early detection, the infographic features diagnostic tools like OCT scans and visual field tests, emphasizing the need to protect your vision early.
Understanding Glaucoma: Often called the "silent thief of sight," glaucoma can develop without symptoms, posing a risk to those with high blood pressure, age over 40, specific ethnic backgrounds, and myopia. Highlighting the importance of early detection, the infographic features diagnostic tools like OCT scans and visual field tests, emphasizing the need to protect your vision early.

Glaucoma is often described as a single disease, but in reality, it is a group of conditions that damage the optic nerve—the vital connection that carries visual information from your eyes to your brain. When this nerve is compromised, vision loss follows, usually starting subtly in the peripheral field and progressing inward. While elevated eye pressure is commonly associated with glaucoma, it is not the whole story. Many patients develop significant optic nerve damage even with “normal” eye pressure, a condition known as normal-tension glaucoma. This complexity is what makes early diagnosis so challenging and why glaucoma can quietly progress for years.



One of the most difficult aspects of glaucoma is that it rarely announces itself. Most people feel no pain and notice no immediate changes in their vision. The brain is remarkably good at compensating for gradual losses, especially when peripheral vision is affected first. By the time central vision becomes noticeably impaired, the disease may already be advanced. This is why routine eye exams are not just about updating glasses or contact lenses; they are critical medical evaluations that can uncover disease long before symptoms appear.



At South Bay Retina, glaucoma evaluation goes beyond a single pressure reading. A comprehensive approach is essential. This includes detailed examination of the optic nerve’s structure, assessment of the retinal nerve fiber layer, visual field testing, and advanced imaging such as Optical Coherence Tomography (OCT). We also incorporate electrophysiology, which allows us to measure how well visual signals travel from the eye to the brain. These objective tools can reveal dysfunction years before traditional testing detects changes, offering a crucial window for early intervention.

Risk factors for glaucoma extend well beyond eye pressure alone. Age plays a significant role, with risk increasing after 40. Family history raises concern, as genetics strongly influence susceptibility. Nearsightedness, certain medications like long-term steroid use, and systemic conditions such as high blood pressure all contribute. Ethnicity also matters, as individuals of African, Hispanic, or Asian descent face higher risks for specific glaucoma types. This is why glaucoma care must be personalized, taking into account both ocular findings and overall health (The Silent Thief of Sight).



A common and important question patients ask is whether glaucoma can be cured. At this time, there is no cure. However, glaucoma can be effectively controlled. The goal of treatment is to slow or stop progression and preserve existing vision. This often involves lowering eye pressure through medications, laser therapy, or surgery, but modern care also focuses on optimizing optic nerve health and addressing systemic factors that influence blood flow and nerve resilience. With early detection and consistent management, most patients maintain functional vision for life.



The most practical takeaway is simple but powerful: do not wait for symptoms. Regular, comprehensive eye exams—especially if you are over 40 or have risk factors—are the best defense against glaucoma-related vision loss. Early detection changes everything. It transforms glaucoma from a silent threat into a manageable condition with a clear plan forward.

If you or a loved one have concerns about glaucoma or have not had a thorough eye evaluation recently, now is the right time to act. Protecting your vision starts with understanding it.



Have you ever wondered how a condition can slowly steal vision without causing pain, redness, or obvious warning signs? This is exactly why glaucoma remains one of the most misunderstood and underestimated eye diseases today. Many patients are shocked when they hear the diagnosis, not because they ignored symptoms, but because there were none to notice. Understanding glaucoma is the first and most powerful step toward protecting your sight.



Glaucoma is often described as a single disease, but in reality, it is a group of conditions that damage the optic nerve—the vital connection that carries visual information from your eyes to your brain. When this nerve is compromised, vision loss follows, usually starting subtly in the peripheral field and progressing inward. While elevated eye pressure is commonly associated with glaucoma, it is not the whole story. Many patients develop significant optic nerve damage even with “normal” eye pressure, a condition known as normal-tension glaucoma. This complexity is what makes early diagnosis so challenging and why glaucoma can quietly progress for years.



One of the most difficult aspects of glaucoma is that it rarely announces itself. Most people feel no pain and notice no immediate changes in their vision. The brain is remarkably good at compensating for gradual losses, especially when peripheral vision is affected first. By the time central vision becomes noticeably impaired, the disease may already be advanced. This is why routine eye exams are not just about updating glasses or contact lenses; they are critical medical evaluations that can uncover disease long before symptoms appear.



At South Bay Retina, glaucoma evaluation goes beyond a single pressure reading. A comprehensive approach is essential. This includes detailed examination of the optic nerve’s structure, assessment of the retinal nerve fiber layer, visual field testing, and advanced imaging such as Optical Coherence Tomography (OCT). We also incorporate electrophysiology, which allows us to measure how well visual signals travel from the eye to the brain. These objective tools can reveal dysfunction years before traditional testing detects changes, offering a crucial window for early intervention.

Risk factors for glaucoma extend well beyond eye pressure alone. Age plays a significant role, with risk increasing after 40. Family history raises concern, as genetics strongly influence susceptibility. Nearsightedness, certain medications like long-term steroid use, and systemic conditions such as high blood pressure all contribute. Ethnicity also matters, as individuals of African, Hispanic, or Asian descent face higher risks for specific glaucoma types. This is why glaucoma care must be personalized, taking into account both ocular findings and overall health.



A common and important question patients ask is whether glaucoma can be cured. At this time, there is no cure. However, glaucoma can be effectively controlled. The goal of treatment is to slow or stop progression and preserve existing vision. This often involves lowering eye pressure through medications, laser therapy, or surgery, but modern care also focuses on optimizing optic nerve health and addressing systemic factors that influence blood flow and nerve resilience. With early detection and consistent management, most patients maintain functional vision for life.



The most practical takeaway is simple but powerful: do not wait for symptoms. Regular, comprehensive eye exams—especially if you are over 40 or have risk factors—are the best defense against glaucoma-related vision loss. Early detection changes everything. It transforms glaucoma from a silent threat into a manageable condition with a clear plan forward.

If you or a loved one have concerns about glaucoma or have not had a thorough eye evaluation recently, now is the right time to act. Protecting your vision starts with understanding it.



Connect with Us

Phone: (408) 294-3534

Serving: San Jose, Cupertino, and the greater South Bay Area


Facebook: @narain1



References

  1. American Academy of Ophthalmology. (2023). Primary open-angle glaucoma. https://www.aao.org/eye-health/diseases/what-is-glaucoma

  2. National Eye Institute. (2024). Glaucoma. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/glaucoma

  3. Weinreb, R. N., Aung, T., & Medeiros, F. A. (2014). The pathophysiology and treatment of glaucoma: A review. JAMA, 311(18), 1901–1911. https://doi.org/10.1001/jama.2014.3192

  4. Kerrigan-Baumrind, L. A., Quigley, H. A., Pease, M. E., Kerrigan, D. F., & Mitchell, R. S. (2000). Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Investigative Ophthalmology & Visual Science, 41(3), 741–748. https://iovs.arvojournals.org/article.aspx?articleid=2162664

  5. American Academy of Ophthalmology. (2023). Primary open-angle glaucoma. https://www.aao.org/eye-health/diseases/what-is-glaucoma

  6. National Eye Institute. (2024). Glaucoma. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/glaucoma

  7. Weinreb, R. N., Aung, T., & Medeiros, F. A. (2014). The pathophysiology and treatment of glaucoma: A review. JAMA, 311(18), 1901–1911. https://doi.org/10.1001/jama.2014.3192

  8. Kerrigan-Baumrind, L. A., Quigley, H. A., Pease, M. E., Kerrigan, D. F., & Mitchell, R. S. (2000). Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Investigative Ophthalmology & Visual Science, 41(3), 741–748. https://iovs.arvojournals.org/article.aspx?articleid=2162664


WATCH THE FULL EPISODE'S HERE:




LISTEN TO THE PODCAST EPISODES:


Comments


Contact Us

San Jose Office
455 O’Connor Dr
Suite 310
San Jose, CA 95128
Phone: (408) 294-3534
Fax: (408) 294-3214

Gilroy Office
9360 No Name Uno
Suite 210,
Gilroy, CA 95020
Phone: (408) 294-3534
Fax: (408) 294-3214

Call (408) 294-3534 for availability.

© 2025 South Bay Retina

bottom of page